Skip to main content

Table 1 Clinical features of the study groups

From: Safety and tissue yield for percutaneous native kidney biopsy according to practitioner and ultrasound technique

 

Group I (n = 271)

Group II (n = 170)

Group III (n = 217)

Age, years

35.8 ± 14.4

38.6 ± 15.0

36.4 ± 15.9

Male

145 (53.5)

89 (52.4)

112 (51.6)

Weight, kg

62.4 ± 11.2

63.1 ± 13.2

63.9 ± 12.5

Height, cm

165.0 ± 8.8

165.0 ± 9.6

164.5 ± 10.0

BMI, kg/m2

22.9 ± 3.3

23.0 ± 3.7

23.5 ± 3.8

Blood pressure

   

 Systolic, mmHg

118 ± 15

119 ± 14

117 ± 17

 Diastolic, mmHg

74 ± 11

74 ± 12

74 ± 11

Comorbid conditions

   

 Diabetes

5 (1.8)

14 (8.2)a

8 (3.8)

 Hypertension

55 (20.3)

40 (23.5)

42 (19.8)

 SLE

30 (11.1)

30 (17.6)b

11 (5.1)

 Chronic liver disease

10 (3.7)

6 (3.5)

7 (3.2)

  1. Data are presented as mean ± standard deviation or number (percentage).
  2. aGroup II versus Group I, p < 0.005.
  3. bGroup II versus Group III, p = 0.0005.
  4. BMI, body mass index, SLE, systemic lupus erythematosus.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us